adamantane has been researched along with prostaglandin d2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Huang, LT; Lin, YJ; Lu, PC; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Yu, HR | 1 |
1 other study(ies) available for adamantane and prostaglandin d2
| Article | Year |
|---|---|
Early postnatal treatment with soluble epoxide hydrolase inhibitor or 15-deoxy-Δ(12,14)-prostagandin J2 prevents prenatal dexamethasone and postnatal high saturated fat diet induced programmed hypertension in adult rat offspring.
Topics: Adamantane; Angiotensin-Converting Enzyme 2; Animals; Arachidonic Acid; Dexamethasone; Diet, High-Fat; Epoxide Hydrolases; Female; Humans; Hypertension; Lauric Acids; Nitric Oxide; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Prostaglandin D2; Rats; Receptor, Angiotensin, Type 2 | 2016 |